Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy

Published:2018-04 Issue:4 Volume:26 Page:1008-1019
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ricca Jacob M.,Oseledchyk Anton,Walther Tyler,Liu Cailian,Mangarin Levi,Merghoub Taha,Wolchok Jedd D.,Zamarin Dmitriy

Funder

NIH

Ludwig Institute for Cancer Research

Swim Across America

Damon Runyon Cancer Research Foundation

Ovarian Cancer Research Foundation

Bladder Cancer Awareness Network

MSKCC Cycle for Survival

Department of Defense Ovarian Cancer Research Academy

Parker Institute for Cancer Immunotherapy

MSKCC Cancer Immunotherapy Program

NCI

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference32 articles.

1. Oncolytic viruses: a new class of immunotherapy drugs;Kaufman;Nat. Rev. Drug Discov.,2015

2. Oncolytic virotherapy;Russell;Nat. Biotechnol.,2012

3. The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon;Prestwich;Hum. Gene Ther.,2009

4. Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy;Chen;Hum. Gene Ther.,2000

5. Systemic delivery of oncolytic viruses: hopes and hurdles;Ferguson;Adv. Virol.,2012

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the effect of reduced temperatures on the efficacy of rhabdovirus-based viral vector platforms;Journal of General Virology;2024-08-22

2. Nanosynergist-engineered oncolytic adenovirus enhancing immune-virotherapy efficacy for glioblastoma via interrupting antiviral responses;Nano Today;2024-08

3. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments;Cancer Cell International;2024-07-11

4. The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?;Vaccines;2024-06-28

5. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3